Last update 10 Sep 2026

XS-02

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
FXS7490, XS 02, XS02
Target
Chk1
Action
inhibitors
Mechanism
Chk1 inhibitors(Checkpoint kinase 1 inhibitors)
Therapeutic Areas
NeoplasmsEndocrinology and Metabolic DiseaseSkin and Musculoskeletal Diseases+ [1]
Active Indication
Breast CancerEndometrial CarcinomaLocally Advanced Malignant Solid Neoplasm+ [2]
Inactive Indication-
Originator Organization
NovaOnco JS Therapeutics Co., Ltd.
Active Organization
NovaOnco JS Therapeutics Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with XS-02
NCT06531486
/ Not yet recruitingPhase 1/2
A Multicenter, Open Label, Single-arm Phase I/II Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Initial Efficacy of XS-02 Capsules in Patients With Advanced Solid Tumors
100 Clinical Results associated with XS-02
Login to view more data
100 Translational Medicine associated with XS-02
Login to view more data
100 Patents (Medical) associated with XS-02
Login to view more data
100 Deals associated with XS-02
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Breast CancerPhase 2-
NovaOnco JS Therapeutics Co., Ltd.
29 Jul 2024
Endometrial CarcinomaPhase 2-
NovaOnco JS Therapeutics Co., Ltd.
29 Jul 2024
Locally Advanced Malignant Solid NeoplasmPhase 2-
NovaOnco JS Therapeutics Co., Ltd.
29 Jul 2024
Recurrent ovarian cancerPhase 2-
NovaOnco JS Therapeutics Co., Ltd.
29 Jul 2024
Advanced Malignant Solid NeoplasmPhase 2
China
NovaOnco JS Therapeutics Co., Ltd.
19 Jun 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free